journal article·2022-08-24

Multistep Crystallization of Pharmaceutical Amorphous Nanoparticles via a Cognate Pathway of Oriented Attachment: Direct Evidence of Nonclassical Crystallization for Organic Molecules

Ziqiao Chen, Kenjirou Higashi, Keisuke Ueda, Kunikazu Moribe

Nano Letters· Volume 22· Issue 16
Publisher page

Abstract

Crystallization of organic molecules is important in a wide range of scientific disciplines. However, in contrast to maturely studied crystallization of inorganic materials, the crystallization mechanisms of organic molecules involving nucleation and crystal growth are still poorly understood. Here, we used time-resolved cryogenic transmission electron microscopy to directly map the morphological evolution of amorphous cyclosporin A (CyA) nanoparticles during CyA crystallization. We successfully observed its initial nucleation and found that the amorphous CyA nanoparticles crystallized via a pathway cognate with oriented attachment, which is the nonclassical crystallization mechanism usually reported for inorganic compounds. Crystalline mesostructured intermediates (mesocrystals) were formed during crystallization. This study revealed clear and direct evidence of mesocrystal formation and oriented attachment in organic pharmaceuticals, providing new insights into the crystallization of organic molecules and theories of nonclassical crystallization.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallization and Solubility Studies · Calcium Carbonate Crystallization and Inhibition · Crystallography and molecular interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan

Funding

Takeda Science Foundation · Japan Society for the Promotion of Science · Japan Science and Technology Agency · Uehara Memorial Foundation

References (43)

Show source-provided references
1. 10.1002/anie.20120482410.1002/anie.201204824 ↗
2. 10.1021/acs.chemrev.5b0074410.1021/acs.chemrev.5b00744 ↗
3. 10.1126/science.aaa676010.1126/science.aaa6760 ↗
4. 10.1021/jacs.9b0188310.1021/jacs.9b01883 ↗
5. 10.1038/s41467-021-24171-z10.1038/s41467-021-24171-z ↗
6. 10.1038/nature2597110.1038/nature25971 ↗
7. 10.1038/s41586-020-2104-410.1038/s41586-020-2104-4 ↗
8. 10.1021/jp068813i10.1021/jp068813i ↗
9. 10.1002/anie.20170684310.1002/anie.201706843 ↗
10. 10.1038/ncomms1593310.1038/ncomms15933 ↗
11. 10.1021/ar800217x10.1021/ar800217x ↗
12. 10.1016/j.nantod.2011.10.00510.1016/j.nantod.2011.10.005 ↗
13. 10.1021/acs.accounts.0c0073910.1021/acs.accounts.0c00739 ↗
14. 10.1039/B807760F10.1039/B807760F ↗
15. 10.1039/C3NR04717B10.1039/C3NR04717B ↗
16. 10.1126/science.281.5379.96910.1126/science.281.5379.969 ↗
17. 10.1002/anie.20050049610.1002/anie.200500496 ↗
18. 10.1002/adma.20090136510.1002/adma.200901365 ↗
19. 10.1039/C6CS00208K10.1039/C6CS00208K ↗
20. 10.1038/s41570-019-0129-810.1038/s41570-019-0129-8 ↗
21. 10.1126/science.121918510.1126/science.1219185 ↗
22. 10.1002/anie.20160379410.1002/anie.201603794 ↗
23. 10.1021/acs.cgd.6b0079410.1021/acs.cgd.6b00794 ↗
24. 10.1002/adma.20200158210.1002/adma.202001582 ↗
25. 10.1038/s41598-020-75937-210.1038/s41598-020-75937-2 ↗
26. 10.1021/acscentsci.8b0028910.1021/acscentsci.8b00289 ↗
27. 10.1021/acs.molpharmaceut.9b0015810.1021/acs.molpharmaceut.9b00158 ↗
28. 10.1038/ncomms659810.1038/ncomms6598 ↗
29. 10.1038/s41467-019-11887-210.1038/s41467-019-11887-2 ↗
30. 10.1021/acs.molpharmaceut.1c0072110.1021/acs.molpharmaceut.1c00721 ↗
31. 10.1021/jacs.0c0559110.1021/jacs.0c05591 ↗
32. 10.1103/PhysRevLett.103.22570310.1103/PhysRevLett.103.225703 ↗
33. 10.1002/ddr.2162210.1002/ddr.21622 ↗
34. 10.1021/ja042561m10.1021/ja042561m ↗
35. 10.1021/cg101518f10.1021/cg101518f ↗
36. 10.1038/s41586-021-03300-010.1038/s41586-021-03300-0 ↗
37. 10.1016/j.actamat.2015.02.03010.1016/j.actamat.2015.02.030 ↗
38. 10.1002/anie.20191098610.1002/anie.201910986 ↗
39. 10.1021/acscentsci.1c0025410.1021/acscentsci.1c00254 ↗
40. 10.1016/j.ejps.2013.03.01610.1016/j.ejps.2013.03.016 ↗
41. 10.1021/mp500303a10.1021/mp500303a ↗
42. 10.1002/jps.2401610.1002/jps.24016 ↗
43. 10.1038/s41557-020-0542-010.1038/s41557-020-0542-0 ↗